StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a report published on Thursday. The firm issued a sell rating on the biotechnology company’s stock. Several other research firms also recently issued reports on NSTG. Canaccord Genuity Group reaffirmed a buy rating and set a $10.00 price objective on shares of […]